SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-108825
Filing Date
2021-04-07
Accepted
2021-04-07 16:01:57
Documents
12
Period of Report
2021-04-05
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d153242d8k.htm   iXBRL 8-K 21624
  Complete submission text file 0001193125-21-108825.txt   131908

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cydy-20210405.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20210405_lab.xml EX-101.LAB 16083
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20210405_pre.xml EX-101.PRE 10118
5 EXTRACTED XBRL INSTANCE DOCUMENT d153242d8k_htm.xml XML 3002
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 21812080
SIC: 2834 Pharmaceutical Preparations